Amgen Inc. (AMGN) BofA Securities 2024 Health Care Conference (Transcript)

Amgen Inc. (NASDAQ:AMGN) BofA Securities 2024 Health Care Conference May 14, 2024 ET Company Participants Peter Griffith - EVP & CFO James Bradner - EVP, Research and Development & Chief Scientific Officer Justin Claeys - VP, IR Conference Call Participants Geoff Meacham - BofA Securities Peter Griffith [Call Starts Abruptly] for the Phase II study is complete and that we are confident in MariTide's differentiated profile and are actively planning a broad Phase 3 program, including obesity, obesity-related ...